Novartis to present new findings of Enerzair Breezhaler at ERS congress
06 Sep 2021 //
PHARMABIZ
Novartis phase III IRIDIUM study show reduced severe asthma exacerbation rates
07 Sep 2020 //
PHARMABIZ
High-dose Enerzair Breezhaler further cuts asthma exacerbations
07 Sep 2020 //
PHARMATIMES
Novartis Phase III IRIDIUM data in Lancet Respiratory Medicine show of Enerzair®
10 Jul 2020 //
PRESS RELEASE